1
|
Cervantes JM, Gomez E. Effect of an aperture in atomic gravimetry. JOURNAL OF THE OPTICAL SOCIETY OF AMERICA. A, OPTICS, IMAGE SCIENCE, AND VISION 2024; 41:881-891. [PMID: 38856575 DOI: 10.1364/josaa.503050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Accepted: 03/29/2024] [Indexed: 06/11/2024]
Abstract
There is a continuous interest in shrinking the dimensions of portable atomic gravimeters. This inevitably ends up truncating the Gaussian wings of the excitation laser beams whose effect has not been properly quantified yet. The diffraction pattern created from this aperture creates ripples in the wavefront in both the phase and the intensity. We calculate the shift in the measured value of an atomic gravimeter introduced by the phase variations in the wavefront. Fortunately, this shift has a Gaussian decay with the aperture size. For extended clouds, we observe a reduction of the effect thanks to an averaging over transverse positions with different values of the shift. Surprisingly, we found that the intensity variations also introduce an important correction to the photon recoil, which contributes at about the same level as the previous shift in the measurement of the gravitational acceleration. Our results should help decide how small an apparatus can be to guarantee a particular accuracy.
Collapse
|
2
|
Castaño-Ortiz JM, Courant F, Gomez E, García-Pimentel MM, León VM, Campillo JA, Santos LHMLM, Barceló D, Rodríguez-Mozaz S. Combined exposure of the bivalve Mytilus galloprovincialis to polyethylene microplastics and two pharmaceuticals (citalopram and bezafibrate): Bioaccumulation and metabolomic studies. JOURNAL OF HAZARDOUS MATERIALS 2023; 458:131904. [PMID: 37356174 DOI: 10.1016/j.jhazmat.2023.131904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Revised: 06/09/2023] [Accepted: 06/19/2023] [Indexed: 06/27/2023]
Abstract
Pharmaceuticals and microplastics constitute potential hazards in aquatic systems, but their combined effects and underlying toxicity mechanisms remain largely unknown. In this study, a simultaneous characterization of bioaccumulation, associated metabolomic alterations and potential recovery mechanisms was performed. Specifically, a bioassay on Mediterranean mussels (Mytilus galloprovincialis) was carried out with polyethylene microplastics (PE-MPLs, 1 mg/L) and citalopram or bezafibrate (500 ng/L). Single and co-exposure scenarios lasted 21 days, followed by a 7-day depuration period to assess their potential recovery. PE-MPLs delayed the bioaccumulation of citalopram (lower mean at 10 d: 447 compared to 770 ng/g dw under single exposure), although reaching similar tissue concentrations after 21 d. A more limited accumulation of bezafibrate was observed overall, regardless of PE-MPLs co-exposure (<MQL-3.2 ng/g dw). Metabolic profiles showed a strong effect of pharmaceuticals, generally independent of PE-MPLs co-exposure. Alterations of the citrate cycle (bezafibrate exposure) and steroid and prostaglandin metabolism (citalopram and bezafibrate exposures) were highlighted. PE-MPLs alone also impacted metabolic pathways, such as neurotransmitters or purine metabolism. After depuration, relevant latent or long-lasting effects were demonstrated as, for instance, the effect of citalopram on neurotransmitters metabolism. Altogether, the observed molecular-level responses to pharmaceuticals and/or PE-MPLs may lead to a dysregulation of mussels' reproduction, energy metabolism, and/or immunity.
Collapse
|
3
|
López-Vázquez A, Maldonado MA, Gomez E, Corzo NV, de Carlos-López E, Franco Villafañe JA, Jiménez-García K, Jiménez-Mier J, López-González JL, López-Monjaraz CJ, López-Romero JM, Medina Herrera A, Méndez-Fragoso R, Ortiz CA, Peña H, Raboño Borbolla JG, Ramírez-Martínez F, Valenzuela VM. Compact laser modulation system for a transportable atomic gravimeter. OPTICS EXPRESS 2023; 31:3504-3519. [PMID: 36785342 DOI: 10.1364/oe.477648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Accepted: 12/16/2022] [Indexed: 06/18/2023]
Abstract
Nowadays, atom-based quantum sensors are leaving the laboratory towards field applications requiring compact and robust laser systems. Here we describe the realization of a compact laser system for atomic gravimetry. Starting with a single diode laser operating at 780 nm and adding only one fiber electro-optical modulator, one acousto-optical modulator and one laser amplifier we produce laser beams at all the frequencies required for a Rb-87 atomic gravimeter. Furthermore, we demonstrate that an atomic fountain configuration can also be implemented with our laser system. The modulated system reported here represents a substantial advance in the simplification of the laser source for transportable atom-based quantum sensors that can be adapted to other sensors such as atomic clocks, accelerometers, gyroscopes or magnetometers with minor modifications.
Collapse
|
4
|
Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P. [French practical guidelines for the diagnosis and management of IPF - 2021 update, full version]. Rev Mal Respir 2022; 39:e35-e106. [PMID: 35752506 DOI: 10.1016/j.rmr.2022.01.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated. METHODS Under the auspices of the French-speaking Learned Society of Pulmonology and at the initiative of the coordinating reference center, practical guidelines for treatment of rare pulmonary diseases have been established. They were elaborated by groups of writers, reviewers and coordinators with the help of the OrphaLung network, as well as pulmonologists with varying practice modalities, radiologists, pathologists, a general practitioner, a head nurse, and a patients' association. The method was developed according to rules entitled "Good clinical practice" in the overall framework of the "Guidelines for clinical practice" of the official French health authority (HAS), taking into account the results of an online vote using a Likert scale. RESULTS After analysis of the literature, 54 recommendations were formulated, improved, and validated by the working groups. The recommendations covered a wide-ranging aspects of the disease and its treatment: epidemiology, diagnostic modalities, quality criteria and interpretation of chest CT, indication and modalities of lung biopsy, etiologic workup, approach to familial disease entailing indications and modalities of genetic testing, evaluation of possible functional impairments and prognosis, indications for and use of antifibrotic therapy, lung transplantation, symptom management, comorbidities and complications, treatment of chronic respiratory failure, diagnosis and management of acute exacerbations of fibrosis. CONCLUSION These evidence-based guidelines are aimed at guiding the diagnosis and the management in clinical practice of idiopathic pulmonary fibrosis.
Collapse
|
5
|
Tayeb KB, Eliard C, Vezin H, Gabrielle B, Delebecq E, Gomez E. In situ EPR investigation of sulfur vulcanization mechanism and ageing process. Polym Degrad Stab 2022. [DOI: 10.1016/j.polymdegradstab.2022.110066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Syrykh C, Schiratti JB, Brion E, Joubert C, Baia M, Marlot L, Maussion C, Danneaux LW, Bologna S, Briere J, Dartigues P, Gaulard P, Haioun C, Jardin F, Molina T, Tilly H, Gomez E, Sondaz D, Copie-Bergman C, Laurent C. 623MO Machine learning-based prediction of germinal center, MYC/BCL2 double protein expressor status, and MYC rearrangement from whole slide images in DLBCL patients. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
7
|
Castilla JA, Almunia N, Brualla A, Jiménez R, Villaquirán AM, Har-vardi I, Ben-Meir A, Gomez E. O-067 Artificial intelligence system detects “goldilocks” morphokinetic zone for embryos transferred or frozen in time-lapse videos. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Are there specific morphokinetic time points which can be used to determine whether an embryo should be discarded?
Summary answer
Morphokinetic ranges where embryos will be discarded rather than transferred or cryopreserved, can be defined using time-lapse annotations automatically generated with artificial intelligence (AI).
What is known already
Time-lapse incubation has changed the way embryos are selected. Instead of static daily observations, continuous monitoring of embryos allows for generation of morphokinetic parameters which quantify the pace of development. However, annotations by humans have been shown to incur operator variations and are time-consuming to perform. AI can automatically annotate embryos with equivalence in accuracy to experienced embryologists. Although most embryo selection methods are designed to identify the embryo with the highest chance of becoming a healthy live birth baby, the ability to identify embryos that will not be suitable for treatment is equally important for clinical decision making.
Study design, size, duration
This is a prospective, observational, cohort study. Time-lapse videos from 142 embryos from a private fertility clinic in Spain were automatically annotated using CHLOE (Fairtility), an AI-based software. CHLOE automatically generated the following morphokinetic parameters: tPNa, tPNf, t2, t3, t4, t5, t6, t7, t8, t9+, tM, tSB, tB, tEB.
Participants/materials, setting, methods
Embryos analysed were from donor and own oocyte’s treatments. Selected embryos were analysed using CHLOE, to automatically identify morphokinetic parameters. The distribution for each morphokinetic parameter was compared between fates (data presented for transferred + frozen vs discarded as mean+-standard deviation, 2-sided t-test). Each continuous morphokinetic parameter was categorised according to the ranges where embryo utilisation was futile (<1%), optimal (maximum utilisation rate) or reduced utilisation rate (between optimal and futile).
Main results and the role of chance
For every morphokinetic parameter the difference in event time between frozen+transferred vs discarded embryos was statistically significant(p < 0.003). The results detail the time point in hours for each morphokinetic feature to occur (mean(SD) frozen+transferred vs discarded, p-value):
tPNa (7.68(2.03)vs22.04(27.15),p<0.0001),
tPNf (21.71(2.86)vs34.63(24.11),p<0.0001),
t2 (24.92(2.71)vs33.78(16.17),p<0.0001),
t3 (34.62(4.03)vs42.58(22),p=0.0024),
t4 (37.29(4.31)vs48.29(20.29,p<0.0001),
t5 (47.03(6.47)vs55.32(22.63),p=0029),
t6 (49.54(5.63)vs60.56(22.20),p<0.0001),
t7 (53.1(7.86)vs69.13(24.54),p<0.0001),
t8 (57.78(9.78)vs77.33(25.79),p<0.0001),
t9+ (69.14(7.39)vs81.9(21.96),p<0.0001),
tM (83.9(8.72)vs96.08(16.88),p<0.0001),
tSB (97.89(7.55)vs105.38(11.38),p=0.0005),
tB (105.74(7)vs113.25(15.53),p=0.0002),
eEB (110.65(7.58)vs120.47(11.36),p=0.0031).
When looking at the exact distribution of these embryos according to time, it became apparent that a goldilocks zone appeared whereby the proportion of embryos transferred or frozen peaked, and the number discarded was at its minimum. The converse was true when looking at the more extreme values of a particular parameter. Thus, we were able to determine the (optimal vs futile time ranges): tPNa (4.4-8.8 hours, where the utilization rate was at its maximum vs < 4.4 or > 13.7, where the utilization rate was at its minimum), tPNf (19.1-23.2vs<9.4,>28.9), t2 (23.-36.4vs<19.9,>33.6), t3 (32.1-37.4vs>24.6,>43), t4 (34-40.2vs<29.5,>55), t5 (42.7-52vs<33.7, >63.5), t6 (45-4-54.2vs<36.10,>63.70), t7 (47.8-56.7vs<42.8,>77.5), t8 (49.2-64.5 vs <44.5,>82.5), t9+ (64.1-74.2vs<57,>90), tM (76.6-92.6 vs <64.7,>104.2), tSB (91.2-105vs<81.3,>113.8), tB(97.2-111.2 vs <92,>118.7), tEB (103.4-116.7,<94.7,>122.5).
A 60% of the embryos were in the futile range in at least 1 parameter, from which only 1 in 3 were utilised.
Limitations, reasons for caution
This is a single centre study. Further work will (i) test the limits across different clinics, with different geographical demographic variations, and varied clinical practices, to understand how these factors affect the limits between futile and optimal ranges of morphokinetics, and (ii) assess clinical outputs (implantation, ploidy, live birth).
Wider implications of the findings
Identifying objective ranges for determining when an embryo is not suitable for treatment will help reduce variation between and within embryologists and clinics; will avoid overly optimistic decisions which waste time and resources and increase patient’s emotional burden, and increase professional confidence when selecting embryos for discarding, transfer or freezing
Trial registration number
not applicable
Collapse
|
8
|
Briongos Figuero S, Estevez Paniagua A, Sanchez Hernandez A, Gomez E, Jimenez S, Vaqueriza Cubillo D, Cortes Beringola A, Munoz-Aguilera R. AV synchronous pacing in patients implanted with leadless pacemakers: a real-world cohort study. Europace 2022. [DOI: 10.1093/europace/euac053.422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Backgroung
Leadless pacemakers (LPM) were developed to overcome complications related to endovenous devices. Devices carrying an accelerometer-based atrial sensing algorithm provided good AV synchrony in a 5-hours study.
Methods
Prospective study of patients implanted with LPM capable of AV synchronous pacing at our institution. We performed a close follow-up consisting of device check-ups 24 h after the implant and 1-3-6-12 months later. Changes in programming were guided by device counters and rate histograms. Once AV synchrony derived from counters (AM-VP + AM-VS) remained stable for at least two consecutive months, a 24 hours Holter monitoring was performed. ECG recordings were automatically and blindly analyzed with a delineation system based on the wavelet transform developed by Martinez et al.1 Cardiac cycles were defined as synchronous if a ventricular event followed the P-wave by ≤300 ms. AV synchrony was calculated by dividing the number of synchronous cycles by the total number of cardiac cycles.
Our aim was to describe AV synchrony in a real-world setting and to determine which echocardiographic and programming parameters were related to optimal AV synchrony (≥85% of total cardiac cycles).
Results
A total of 18 patients (12 males, mean age 82.6 ±8.1) were included. Indications for pacing were complete AV block (n=10) and second-degree AV block (n=8). Device reprogramming was needed in all patients at follow-up. The 24 h Holter monitoring was performed 118.8±43.8 days after the implant. Implant data and, device settings and programming at Holter date is displayed in Table 1. One patient was excluded from the analysis due to the development of severe sinus node disease. Total ECG recorded time was 386.8 hours and 1,537,995 cardiac cycles were analyzed.
Median AV synchrony, after Holter monitoring analysis, was 88.2% (interquartile range 79.9-95,1%) and 12 out of 17 patients showed an AV synchrony ≥85% of cardiac cycles. Optimal AV synchrony was related to smaller right atrium size (13.2±3.4 cm2 vs 15.6±1.2 cm2 for AV synchrony ≥85 and <85%, respectively) but no association appeared between diastolic parameters (E, A, E/A ratio, E´, A´) and AV synchrony. Rate smoothing algorithm was associated with higher rates of optimal AV synchrony (81.8% of patients with algorithm OFF vs 50% of patients activated). Besides, higher A3 threshold (7.1±3.5 m/s2 vs 4.2 ± 1.1 m/s2) and longer A3 window (620.8±25.7 ms vs 600 ms for AV synchrony ≥85% and <85%, respectively) were also linked to optimal AV synchrony. Multivariate analysis did not show any independent predictor of AV synchrony.
Conclusions
In our cohort of LPM patients we obtained high percentages of AV synchronous pacing in a real-life setting. Device reprogramming was often needed, and larger studies are desirable to confirm our data.
Collapse
|
9
|
Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P. [French practical guidelines for the diagnosis and management of IPF - 2021 update, short version]. Rev Mal Respir 2022; 39:275-312. [PMID: 35304014 DOI: 10.1016/j.rmr.2022.01.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Since the previous French guidelines were published in 2017, substantial additional knowledge about idiopathic pulmonary fibrosis has accumulated. METHODS Under the auspices of the French-speaking Learned Society of Pulmonology and at the initiative of the coordinating reference center, practical guidelines for treatment of rare pulmonary diseases have been established. They were elaborated by groups of writers, reviewers and coordinators with the help of the OrphaLung network, as well as pulmonologists with varying practice modalities, radiologists, pathologists, a general practitioner, a head nurse, and a patients' association. The method was developed according to rules entitled "Good clinical practice" in the overall framework of the "Guidelines for clinical practice" of the official French health authority (HAS), taking into account the results of an online vote using a Likert scale. RESULTS After analysis of the literature, 54 recommendations were formulated, improved, and validated by the working groups. The recommendations covered a wide-ranging aspects of the disease and its treatment: epidemiology, diagnostic modalities, quality criteria and interpretation of chest CT, indication and modalities of lung biopsy, etiologic workup, approach to familial disease entailing indications and modalities of genetic testing, evaluation of possible functional impairments and prognosis, indications for and use of antifibrotic therapy, lung transplantation, symptom management, comorbidities and complications, treatment of chronic respiratory failure, diagnosis and management of acute exacerbations of fibrosis. CONCLUSION These evidence-based guidelines are aimed at guiding the diagnosis and the management in clinical practice of idiopathic pulmonary fibrosis.
Collapse
|
10
|
Valentin S, Maurac A, Mandry D, Selton-Suty C, Huttin O, Cherifi A, Guillaumot A, Gomez E, Chabot F, Chaouat A. Place de l’IRM cardiaque dans l’hypertension artérielle pulmonaire et l’hypertension pulmonaire thrombo-embolique chronique. Rev Mal Respir 2022; 39:486-497. [DOI: 10.1016/j.rmr.2022.03.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2021] [Accepted: 02/14/2022] [Indexed: 01/26/2023]
|
11
|
Benitez J, Berumen L, Galvan C, Gomez E. Successful catheter ablation of para-Hisian premature ventricular complex. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2022. [DOI: 10.1016/j.acvdsp.2021.09.175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
12
|
Giordano R, Máñez Costa M, Pagano A, Mayor Rodriguez B, Zorrilla-Miras P, Gomez E, Lopez-Gunn E. Combining social network analysis and agent-based model for enabling nature-based solution implementation: The case of Medina del Campo (Spain). THE SCIENCE OF THE TOTAL ENVIRONMENT 2021; 801:149734. [PMID: 34467897 DOI: 10.1016/j.scitotenv.2021.149734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 08/13/2021] [Accepted: 08/13/2021] [Indexed: 06/13/2023]
Abstract
Several barriers still hamper the effective implementation of Nature-Based Solutions (NBS). Among the others, this work focuses on collaboration barriers. NBS implementation claims for effective collaboration among different decision-agents. However, ambiguity in problem framings, which is ineradicable in multi-agents' decision environments, could create collaboration barriers. This work aims to demonstrate that collaboration barriers to NBS implementation can be overcome by enhancing the network of interactions among the decision-agents. An innovative method based on the integration between Social Network Analysis and hybrid Agent-Based Model/System Dynamic Model was adopted to this aim. The analysis results were used for designing networking interventions, i.e. efforts using social network characteristics that could enhance interactions mechanisms among decision-agents. The developed method was implemented in the Medina del Campo (Spain) case study. This area is characterised by one of the most critical groundwater bodies of the Duero River Basin. This work aims at supporting the implementation of suitable NBS to stop the degradation of the groundwater status and associated ecosystem services. The activities carried out within the framework of the NAIAD project showed that, by enhancing the interaction mechanisms, ambiguity in problem frames can still yield collective actions for NBS implementation.
Collapse
|
13
|
de Luis DA, Izaola O, Primo D, Gomez E, Lopez J. Cholesteryl ester transfer protein rs5833 genetic variant affect HDL-cholesterol levels and ratio total cholesterol/HDL-cholesterol in postmenopausal obese female patient. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 25:7030-7036. [PMID: 34859866 DOI: 10.26355/eurrev_202111_27253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE One SNP in exon 9 (r5883) has been involved with high risk of cardiovascular disease in hypertensive subjects. The goal of the present study was to test the role of this genetic variant on lipid levels and Metabolic Syndrome (MS) in menopausal obese females. PATIENTS AND METHODS The study enrolled a sample of 112 menopausal obese females. Measurements of adiposity parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C reactive protein and prevalence of MS were recorded. Genotype of CETP gene polymorphism (rs5883) was studied. RESULTS The distribution of the rs5883 polymorphism in this menopausal obese population was 83.9% (n=94) (CC), 15.2% (n=17) (CT) and 0.9% (n=1) (TT). Adiposity parameters, blood pressure, fasting glucose levels, insulin levels, HOMA-IR, C reactive protein, total cholesterol, LDL-cholesterol and triglycerides were similar in both genotype groups (CC vs. CT+TT). Moreover, HDL cholesterol (8.5+1.2 mg/dl; p=0.01) and ratio total cholesterol/HDL-cholesterol (0.5±0.2; p=0.04) were higher in T allele carriers (dominant model). MS percentage was similar in both genotypes (37.6% vs. 27.2%; p=0.43). Logistic regression analysis showed a decreased risk of low-HDL cholesterol in T allele carriers (OR=0.18, 95% CI=0.02-0.77, p=0.03) after adjusting by dietary fatty acid intakes, body mass index and age. CONCLUSIONS The results reported here support that CETP variant rs5883 is related with HDL-cholesterol levels and ratio total cholesterol/HDL-cholesterol.
Collapse
|
14
|
Gimeno I, García-Manrique P, Carrocera S, Lopez-Hidalgo C, Valledor L, Martin-Gonzalez D, Gomez E. 61 Noninvasive prediction of pregnancy and birth in cattle by liquid chromatography-high-resolution mass spectrometry analysis of embryo culture medium. Reprod Fertil Dev 2021; 34:266. [PMID: 35231317 DOI: 10.1071/rdv34n2ab61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
15
|
Gimeno I, García-Manrique P, Gatien J, Carrocera S, Goyache F, Berdasco M, Salvetti P, Gomez E. 154 Early metabolic reading of calf fitness in the embryo and the recipient. Reprod Fertil Dev 2021; 34:315. [PMID: 35231362 DOI: 10.1071/rdv34n2ab154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
16
|
Briongos Figuero S, Estevez A, Sanchez A, Jimenez S, Gomez E, Jimenez-Candil B, Ortega T, Naranjo M, Guimera M, Garcia R, Munoz-Aguilera R. Validation of leadless atrioventricular synchronous pacing with Holter-ECG: a pilot study. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The novel MICRA AV leadless pacemaker can provide atrioventricular (AV) synchronous pacing using an accelerometer-based atrial sensing algorithm.
Purpose
To describe the performance of MICRA AV pacemaker in a real-life setting and to determine the agreement between AV synchrony determined by the device counters and AV synchrony obtained by a 24 h ECG Holter test.
Methods
This pilot study included the first ten patients implanted with a MICRA AV leadless pacemaker at our institution. All implants were performed according to standard protocols and under deep sedation. A close follow-up was performed, and atrial sensing parameters were adjusted following AV synchrony given by the device counters. Patients underwent a 24 h ECG Holter test once AV synchrony remained stable for at least two months. The ECG Holter signal was analyzed in a blinded manner by an automatic delineation system based on the wavelet transform (Figure). This algorithm has a sensivity of 98.9% and a positive predictive value of 91.9% to detect p waves. Cardiac cycles were defined as synchronous if a QRS complex followed the P-wave by ≤300 ms, according to MARVEL 2 study criterion. AV synchrony obtained from the 24 h Holter test was compared with AV synchrony extracted from the device counters (AM-VP + AM-VS) during the same 24 h.
Results
From June to November 2020, 10 patients (7 males, mean age 83.5±5.4) were implanted with a MICRA AV leadless pacemaker (5 patients due to complete AV block and 5 patients due to second degree AV block). All devices were implanted after 1 deployment and no major complications appeared. Data related to implant parameters are displayed in Table 1. Device reprogramming was needed in all patients during follow-up. The 24 h ECG Holter monitoring was performed 141.4±45 days after the implant (mean time). Device settings and programming at Holter date is displayed in Table 1. Total ECG recorded time was 210.6 h and 915,488 cardiac cycles were analyzed. The mean percentage of synchronous cardiac cycles was 88.6±8.5% of total cycles while the mean AV synchrony determined by the device counters (AM-VP + AM-VS) during those 24 h was 89.8±5.5%. A good patient to patient correlation between these two measures was found (coefficient of intraclass correlation = 0.72).
Conclusions
We obtained high rates of AV synchrony with MICRA AV leadless pacemaker, in our short-term follow-up pilot study. Manual adjustment of the atrial sensing parameters, guided by the device counters, seems to be useful to obtain an optimal performance.
Funding Acknowledgement
Type of funding sources: None.
Collapse
|
17
|
Gomez Ramos J, Arenas M, Castaño F, Gomez E, Aparicio C, Acosta J, Araguas P, Malave B, Pazos M. PO-1978 Chronic and cosmetic toxicity in patients undergoing radiotherapy and breast reconstruction. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)08429-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
18
|
Ariza-Castro N, Courant F, Dumas T, Marion B, Fenet H, Gomez E. Elucidating venlafaxine metabolism in the Mediterranean mussel (Mytilus galloprovincialis) through combined targeted and non-targeted approaches. THE SCIENCE OF THE TOTAL ENVIRONMENT 2021; 779:146387. [PMID: 34030260 DOI: 10.1016/j.scitotenv.2021.146387] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 03/04/2021] [Accepted: 03/07/2021] [Indexed: 06/12/2023]
Abstract
Exposure of aquatic organisms to antidepressants is currently well documented, while little information is available on how wild organisms cope with exposure to these pharmaceutical products. Studies on antidepressant metabolism in exposed organisms could generate information on their detoxification pathways and pharmacokinetics. The goal of this study was to enhance knowledge on the metabolism of venlafaxine (VEN)-an antidepressant frequently found in aquatic ecosystems-in Mytilus galloprovincialis, a bivalve that is present worldwide. An original tissue extraction technique based on the cationic properties of VEN was developed for further analysis of VEN and its metabolites using targeted and non-targeted approaches. This extraction method was assessed in terms of recovery and matrix effects for VEN metabolites. Commercial analytical standards were applied to characterize metabolites found in mussels exposed to 10 μg/L VEN for 3 and 7 days. Targeted and non-targeted approaches using liquid chromatography (LC) combined with high-resolution mass spectrometry (HRMS) were implemented to screen for expected metabolites based on the literature on aquatic species, and for metabolites not previously documented. Four venlafaxine metabolites were identified, namely N-desmethylvenlafaxine and O-desmethylvenlafaxine, which were clearly identified using analytical standards, and two other metabolites revealed by non-target analysis. According to the signal intensity, hydroxy-venlafaxine (OH-VEN) was the predominant metabolite detected in mussels exposed for 3 and 7 days.
Collapse
|
19
|
Berrier A, Gomez E, Essari LA, Soler J, Petit I, Pierre C, Chabot F, Chaouat A. [IgG4-Related Disease: A rare cause of severe interstitial lung disease]. Rev Mal Respir 2021; 38:530-534. [PMID: 33965265 DOI: 10.1016/j.rmr.2021.02.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 02/09/2021] [Indexed: 10/21/2022]
Abstract
BACKGROUND The intrathoracic manifestations of IgG4-related disease include a range of conditions and severity, and can on occasion cause acute respiratory failure as reported in the case described here. OBSERVATION A 69-year-old male former smoker, was admitted to our hospital with dyspnea, fever, cough, fatigue, and a 3-month history of weight loss. He received high flow oxygen therapy and non-invasive ventilation for severe respiratory failure. Chest computed tomography revealed multifocal condensations and ground glass opacities, accompanied by thickening of the perilymphatic interstitium, mediastinal lymphadenopathy and bilateral pleural effusion. Elevated serum concentrations of IgG4 suggested an IgG4-Related Disease. He developed renal failure and underwent a renal biopsy. Histopathological analysis of which supported the diagnosis by showing dense lymphocytic infiltrate with a count of IgG4+ cells/hpf higher than 60, and storiform fibrosis - a swirling, "cartwheel" pattern of fibrosis which may have a patchy distribution. The patient responded well to steroid therapy. CONCLUSION Although respiratory symptoms are usually mild in IgG4-relatd disease, thoracic features can evolve into acute respiratory failure with few extra thoracic manifestations.
Collapse
|
20
|
Baird AH, Guest JR, Edwards AJ, Bauman AG, Bouwmeester J, Mera H, Abrego D, Alvarez-Noriega M, Babcock RC, Barbosa MB, Bonito V, Burt J, Cabaitan PC, Chang CF, Chavanich S, Chen CA, Chen CJ, Chen WJ, Chung FC, Connolly SR, Cumbo VR, Dornelas M, Doropoulos C, Eyal G, Eyal-Shaham L, Fadli N, Figueiredo J, Flot JF, Gan SH, Gomez E, Graham EM, Grinblat M, Gutiérrez-Isaza N, Harii S, Harrison PL, Hatta M, Ho NAJ, Hoarau G, Hoogenboom M, Howells EJ, Iguchi A, Isomura N, Jamodiong EA, Jandang S, Keyse J, Kitanobo S, Kongjandtre N, Kuo CY, Ligson C, Lin CH, Low J, Loya Y, Maboloc EA, Madin JS, Mezaki T, Min C, Morita M, Moya A, Neo SH, Nitschke MR, Nojima S, Nozawa Y, Piromvaragorn S, Plathong S, Puill-Stephan E, Quigley K, Ramirez-Portilla C, Ricardo G, Sakai K, Sampayo E, Shlesinger T, Sikim L, Simpson C, Sims CA, Sinniger F, Spiji DA, Tabalanza T, Tan CH, Terraneo TI, Torda G, True J, Tun K, Vicentuan K, Viyakarn V, Waheed Z, Ward S, Willis B, Woods RM, Woolsey ES, Yamamoto HH, Yusuf S. An Indo-Pacific coral spawning database. Sci Data 2021; 8:35. [PMID: 33514754 PMCID: PMC7846567 DOI: 10.1038/s41597-020-00793-8] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Accepted: 11/19/2020] [Indexed: 01/30/2023] Open
Abstract
The discovery of multi-species synchronous spawning of scleractinian corals on the Great Barrier Reef in the 1980s stimulated an extraordinary effort to document spawning times in other parts of the globe. Unfortunately, most of these data remain unpublished which limits our understanding of regional and global reproductive patterns. The Coral Spawning Database (CSD) collates much of these disparate data into a single place. The CSD includes 6178 observations (3085 of which were unpublished) of the time or day of spawning for over 300 scleractinian species in 61 genera from 101 sites in the Indo-Pacific. The goal of the CSD is to provide open access to coral spawning data to accelerate our understanding of coral reproductive biology and to provide a baseline against which to evaluate any future changes in reproductive phenology.
Collapse
|
21
|
Esteve-Luque V, Sarasa I, Trias F, Fanlo-Maresma M, Lafuente H, Rodriguez M, Gomez E, Pintó X. Long-term effects of PCSK9I on lipid profile and goal attainment in high cardiovascular risk patients from a real-world clinical setting. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Treffel G, Guillaumot A, Gomez E, Eyries M, Petit I, Chabot JF, Chaouat A. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation]. Rev Mal Respir 2020; 37:823-828. [PMID: 33071063 DOI: 10.1016/j.rmr.2020.09.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Accepted: 08/31/2020] [Indexed: 01/08/2023]
Abstract
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. Heritable and sporadic forms have been distinguished. Hypoxemia, profound reduction in the diffusion of carbon monoxide and haemodynamic confirmation of pre-capillary pulmonary hypertension are the major diagnostic criteria. Thoracic CT scanning and a response to pharmaceutical therapy provide additional information to confirm the diagnosis. A 52-year-old patient, three of whose siblings had pulmonary hypertension, was admitted with dyspnoea, malaise and palpitations. Right heart catheterisation confirmed pre-capillary pulmonary hypertension. A search for an EIF2AK4 mutation was carried out, and this showed a composite biallelic heterozygous mutation compatible with the diagnosis of familial PVOD, identical to that showed in one of his brothers. Given the signs of severity of the disease and the diagnosis of PVOD, whose response to pharmaceutical therapy is often poor, the patient was placed on a waiting list for lung transplantation. Despite a similar diagnosis in 3 brothers and follow-up proposed 11 years before the diagnosis, pulmonary hypertension appeared within a few weeks and led immediately to a severe clinical situation. Annual clinical and echocardiographic monitoring had been strongly advised to the patient, but had not allowed diagnosis at a mild or moderate stage of the disease. This clinical case shows that the identification of factors predicting the development of heritable PVOD at a pre-symptomatic stage is an important issue for clinical research.
Collapse
|
23
|
Drexelius A, Hoellrich A, Jajack A, Gomez E, Brothers M, Hussain S, Kim S, Heikenfeld J. Analysis of pressure-driven membrane preconcentration for point-of-care assays. BIOMICROFLUIDICS 2020; 14:054101. [PMID: 32922588 PMCID: PMC7467750 DOI: 10.1063/5.0013987] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Accepted: 08/07/2020] [Indexed: 06/11/2023]
Abstract
Point-of-care diagnostic devices for both physicians and patients themselves are now ubiquitous, but often not sensitive enough for highly dilute analytes (e.g., pre-symptomatic viral detection). Two primary methods to address this challenge include (1) increasing the sensitivity of molecular recognition elements with greater binding affinity to the analyte or (2) increasing the concentration of the analyte being detected in the sample itself (preconcentration). The latter approach, preconcentration, is arguably more attractive if it can be made universally applicable to a wide range of analytes. In this study, pressure-driven membrane preconcentration devices were developed, and their performance was analyzed for detecting target analytes in biofluids in the form of point-of-care lateral-flow assays (LFAs). The demonstrated prototypes utilize negative or positive pressure gradients to move both water and small interferents (salt, pH) through a membrane filter, thereby concentrating the analyte of interest in the remaining sample fluid. Preconcentration up to 33× is demonstrated for influenza A nucleoprotein with a 5 kDa pore polyethersulfone membrane filter. LFA results are obtained within as short as several minutes and device operation is simple (very few user steps), suggesting that membrane preconcentration can be preferable to more complex and slow conventional preconcentration techniques used in laboratory practice.
Collapse
|
24
|
Ruuth-Praz J, Faure M, Gomez E, Petit I, Petitpain N, Chaouat A, Chabot F. [Eosinophilic pneumonia: A rare complication of sodium divalproate]. Rev Mal Respir 2020; 37:590-594. [PMID: 32739035 DOI: 10.1016/j.rmr.2020.05.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2019] [Accepted: 05/24/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Eosinophilic pneumonias are characterized by an increase in lung eosinophils. These disorders can be induced by drug reactions. CASE REPORT A 57-year-old woman suffering from bipolar disorder and treated by sodium divalproate for more than 2 years was hospitalised in the department of respiratory medicine for dyspnoea and cough. The investigations showed severe hypoxaemia, airflow limitation, multiple ground-glass opacities and crazy paving on the chest CT-scan and a blood eosinophilia. A significant alveolar eosinophilia was found in the broncho-alveolar lavage. A complete assessment of possible causes was made. Finally, we made the diagnosis of eosinophilic pneumonia secondary to sodium divalproate. The treatment was stopped and systemic corticosteroid therapy was not introduced. The patient showed an improvement of her dyspnoea in a few days. Lung function and the CT-scan were normal within a few months. CONCLUSIONS Sodium divalproate, frequently used in the treatment of bipolar disorder, is a rare cause of eosinophilic lung disease, even years after its introduction. Rapid diagnosis and withdrawal of treatment led to complete resolution in the reported case.
Collapse
|
25
|
Hill J, Gomez E, Clegg A. Fathers report experiencing negative feelings and psychological difficulties during the perinatal period. Evid Based Nurs 2020; 24:ebnurs-2020-103287. [PMID: 32709601 DOI: 10.1136/ebnurs-2020-103287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/11/2020] [Indexed: 11/03/2022]
|